Eastman Chemical Company
General ticker "EMN" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $9.2B (TTM average)
Eastman Chemical Company does not follow the US Stock Market performance with the rate: -3.8%.
Estimated limits based on current volatility of 2.2%: low 71.92$, high 75.08$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-12-15, amount 0.84$ (Y4.66%)
- Total employees count: 14000 as of 2024
- China accounted for 11.4% of revenue in the fiscal year ended 2024-12-31
- US accounted for 40.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Geopolitical risks, Supply chain disruptions, Raw material cost volatility, Cybersecurity threats, Regulatory and compliance
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [49.83$, 75.57$]
- 2026-12-31 to 2027-12-31 estimated range: [54.68$, 80.95$]
Financial Metrics affecting the EMN estimates:
- Negative: with PPE of 11.8 at the end of fiscal year the price was high
- Positive: Operating cash flow per share per price, % of 13.30 > 12.96
- Positive: 7.67 < Operating profit margin, % of 10.64
- Negative: 0 < Industry inventory ratio change (median), % of 0.30
- Negative: Industry operating cash flow per share per price (median), % of 5.24 <= 5.46
- Positive: 19.40 < Shareholder equity ratio, % of 40.12 <= 42.68
- Positive: -14.22 < Investing cash flow per share per price, % of -6.34
Short-term EMN quotes
Long-term EMN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $9,198.00MM | $9,382.00MM | $8,752.00MM |
| Operating Expenses | $8,102.00MM | $8,006.00MM | $7,821.00MM |
| Operating Income | $1,096.00MM | $1,376.00MM | $931.00MM |
| Non-Operating Income | $-9.00MM | $-298.00MM | $-363.00MM |
| Interest Expense | $225.00MM | $216.00MM | $208.00MM |
| R&D Expense | $239.00MM | $250.00MM | $255.00MM |
| Income(Loss) | $1,087.00MM | $1,078.00MM | $568.00MM |
| Taxes | $191.00MM | $170.00MM | $93.00MM |
| Profit(Loss)* | $894.00MM | $905.00MM | $474.00MM |
| Stockholders Equity | $5,458.00MM | $5,779.00MM | $5,961.00MM |
| Inventory | $1,683.00MM | $1,988.00MM | $1,980.00MM |
| Assets | $14,633.00MM | $15,213.00MM | $14,859.00MM |
| Operating Cash Flow | $1,374.00MM | $1,287.00MM | $970.00MM |
| Capital expenditure | $828.00MM | $599.00MM | $546.00MM |
| Investing Cash Flow | $-432.00MM | $-534.00MM | $-462.00MM |
| Financing Cash Flow | $-888.00MM | $-454.00MM | $-797.00MM |
| Earnings Per Share** | $7.54 | $7.75 | $4.13 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.